SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion
A recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
Read moreA recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
Read moreA brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read moreTreatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Read moreResearchers based in India have demonstrated that horses inoculated with an inactivated dosage of severe acute respiratory syndrome coronavirus 2
Read moreNew research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus
Read moreWith the current coronavirus disease 2019 (COVID-19) pandemic spreading to almost every country in the world, lockdowns, social distancing and
Read moreSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus behind the coronavirus disease 2019 (COVID-19) pandemic, has claimed over
Read moreThe Zika outbreak of 2015 and 2016 is having lasting impacts on children whose mothers became infected with the virus
Read moreThe current coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been observed to
Read moreIn March of 2020, Shelli Farhadian, MD, Ph.D., assistant professor of medicine (infectious diseases) and neurology, began to see parallels
Read more